Supernus Pharmaceuticals shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Supernus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Supernus Pharmaceuticals held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Supernus Pharmaceuticals by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.2M | 25k | 47.79 |
| 2025-06-30 | $3.5M | 111k | 31.52 |
| 2025-03-31 | $737k | 23k | 32.73 |
| 2024-12-31 | $104k | 2.9k | 36.02 |
| 2024-09-30 | $93k | 3.0k | 30.98 |
| 2024-06-30 | $58k | 2.2k | 26.30 |
| 2024-03-31 | $75k | 2.2k | 33.66 |
| 2023-12-31 | $344k | 12k | 28.68 |
| 2023-09-30 | $327k | 12k | 27.47 |
| 2023-06-30 | $132k | 4.4k | 30.02 |
| 2022-12-31 | $62k | 1.7k | 35.47 |
| 2022-09-30 | $59k | 1.7k | 33.75 |
| 2022-06-30 | $101k | 3.5k | 28.87 |
| 2022-03-31 | $65k | 2.0k | 31.89 |
| 2021-12-31 | $59k | 2.0k | 29.15 |
| 2021-09-30 | $46k | 1.8k | 26.29 |
| 2021-06-30 | $59k | 1.9k | 30.57 |
| 2021-03-31 | $50k | 1.9k | 25.91 |
| 2020-09-30 | $51k | 2.5k | 20.72 |
| 2019-12-31 | $54k | 2.3k | 23.64 |
| 2019-09-30 | $12k | 463 | 25.92 |
| 2018-06-30 | $2.0M | 34k | 59.82 |
| 2018-03-31 | $1.5M | 34k | 45.79 |
| 2017-12-31 | $1.4M | 35k | 39.83 |
| 2017-09-30 | $2.1M | 54k | 40.00 |
| 2017-06-30 | $2.8M | 64k | 43.09 |
| 2017-03-31 | $2.1M | 66k | 31.29 |
| 2016-12-31 | $3.6M | 143k | 25.25 |
| 2016-09-30 | $3.5M | 143k | 24.72 |
| 2016-06-30 | $2.9M | 143k | 20.37 |